Abstract

CD44, cluster of differentiation 44 is a typical marker of stem cells. At present, it has been found that CD44 is prevalent in various human malignant tumors, but its expression regulation mechanism is still not clear. The initiation of gene expression, the modification of RNA levels, and the regulation of protein levels are the main factors affecting the expression level of genes, and the most critical one is the regulation of gene expression by signaling pathways. Up to now, there has been no report on the role of MKL-1 in the cloning of the cd44 promoter. Therefore, this study intends to clone the cd44 gene promoter, construct its luciferase reporter gene vector, transfect the MKL-1 overexpression vector, and analyze how it affects transcriptional activity, in order to further study the expression regulation of cd44. The mechanism provides a powerful tool in the future.

Highlights

  • CD44, cluster of differentiation 44 is a typical stem cell marker

  • Gastric adenocarcinoma highly expresses CD44, and multiple human gastric cancer cell lines (NCI-N87, AGS, MKN-28, MKN-45, MKN-74), it was found that CD44 is expressed in gastric cancer cells and used as a surface of gastric cancer stem cells Marker [12]

  • Some research has found that CD44+ and CD24+ cells were isolated from cancer tissues of 5 patients with gastric cancer

Read more

Summary

Introduction

In the study of breast cancer, CD44 was first discovered and confirmed to be a solid tumor stem cell surface marker molecule [1]. CD44+/CD24+ can be used as markers for gastric cancer stem cells by comparing the self-renewal, differentiation and tumorigenicity of different phenotype tumor cells [13]. MKL-1 (MRTF-A, Myocardinrelated transcriptional factor) is a transcriptional regulator originally discovered as a transcriptional cofactor for the Serum response factor (SRF). It is involved in regulating the expression of smooth muscle cell-specific genes [14; 15]. In Prostate Cancer Cells, some research identified that one compound could block MKL transcription to inhibit prostate cancer cell invasion [18]. This study demonstrates that MKL-1 can promote the promoter activity of CD44 and lay the foundation for subsequent research

Methods
Result
Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.